A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

Banks, online lenders and specialized equipment financing companies offer loans to help you purchase costly equipment and machinery for your business. Many, or all, of the products featured on ...

(‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today reported financial results ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Prerequisite: Strong interest in working with iPS Cells and Derived-Stem Cells. Details, Agenda, and Registration: Mayela Gayosso, Ph.D., iPSC Core Director: [email protected] *Space is limited to ...

(‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today reported financial ...